4,4'-二氨基二苯醚(ODA)

4,4'-二氨基二苯醚(ODA)用途

用于制耐热性塑料如聚酰亚胺树脂、聚马来酰亚胺树脂、聚酰胺酰亚胺树脂、聚酯酰亚胺树脂、环氧树脂、聚氨酯等，也用作交联剂。本品用作环氧树脂的固化剂，固化物热变形温度高，热稳定好，耐化学药品性能及耐水性能优良。
本品是耐热型塑料聚酰胺酰亚胺树脂、聚酯酰亚胺树脂、聚酰亚胺树脂、聚马来酰亚胺树脂等的原料。用作环氧树脂的固化剂，固化物热变形温度高，热稳定好，耐化学药品性能及耐水性能优良。也是耐热型塑料聚酰胺酰亚胺树脂、聚酯酰亚胺树脂、聚酰亚胺树脂、聚马来酰亚胺树脂等的原料。

点击显示

4,4'-二氨基二苯醚(ODA)名称

[ CAS 号 ]:
101-80-4

[ 中文名 ]:
4,4'-二氨基二苯醚

[ 英文名 ]:
4,4'-Oxydianiline

[中文别名 ]:

4,4’-二氨基二苯醚

[英文别名 ]:

Bis(p-aminophenyl) ether
p,p'-Diaminodiphenyl ether
4,4’-Oxydianiline
EINECS 202-977-0
Oxydianiline
4,4'-Diaminodiphenyl ether
4,4-Oxydianiline
4,4'-Oxydianiline
ZR DOR DZ
Benzenamine, 4,4'-oxybis-

4,4'-二氨基二苯醚(ODA)物理化学性质

[ 密度 ]:
1.2±0.1 g/cm3

[ 沸点 ]:
389.4±27.0 °C at 760 mmHg

[ 熔点 ]:
188-192 °C(lit.)

[ 分子式 ]:
C₁₂H₁₂N₂O

[ 分子量 ]:
200.236

[ 闪点 ]:
218.9±0.0 °C

[ 精确质量 ]:
200.094955

[ PSA ]:
61.27000

[ LogP ]:
0.51

[ 外观性状 ]:
无气味的无色晶体或一种无气味的细,米色粉末

[ 蒸汽压 ]:
0.0±0.9 mmHg at 25°C

[ 折射率 ]:
1.666

[ 储存条件 ]:
室温

[ 稳定性 ]:
Stable. Combustible. Incompatible with strong oxidizing agents. Hygroscopic.

[ 水溶解性 ]:
Insoluble.

4,4'-二氨基二苯醚(ODA)MSDS

详细MSDS(安全技术说明书)

4,4'-二氨基二苯醚(ODA)毒性和生态

CHEMICAL IDENTIFICATION

RTECS NUMBER :: BY7900000

CHEMICAL NAME :: Aniline, 4,4'-oxydi-

CAS REGISTRY NUMBER :: 101-80-4

BEILSTEIN REFERENCE NO. :: 0475735

LAST UPDATED :: 199710

DATA ITEMS CITED :: 43

MOLECULAR FORMULA :: C12-H12-N2-O

MOLECULAR WEIGHT :: 200.26

WISWESSER LINE NOTATION :: ZR DOR DZ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 725 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 365 mg/kg

TOXIC EFFECTS :: Behavioral - muscle weakness Lungs, Thorax, or Respiration - dyspnea Nutritional and Gross Metabolic - body temperature decrease

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 685 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 300 mg/kg

TOXIC EFFECTS :: Behavioral - muscle weakness Lungs, Thorax, or Respiration - dyspnea Nutritional and Gross Metabolic - body temperature decrease

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rabbit

DOSE/DURATION :: 700 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - rabbit

DOSE/DURATION :: 650 mg/kg

TOXIC EFFECTS :: Behavioral - muscle weakness Lungs, Thorax, or Respiration - dyspnea Nutritional and Gross Metabolic - body temperature decrease

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - guinea pig

DOSE/DURATION :: 650 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 4277 mg/kg/13W-C

TOXIC EFFECTS :: Endocrine - thyroid weight (goiter) Endocrine - other changes Nutritional and Gross Metabolic - weight loss or decreased weight gain

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 619 mg/kg/26W-I

TOXIC EFFECTS :: Cardiac - EKG changes not diagnostic of specified effects Vascular - BP elevation not characterized in autonomic section

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 1087 mg/kg/15D-I

TOXIC EFFECTS :: Endocrine - changes in adrenal weight Endocrine - changes in spleen weight Blood - pigmented or nucleated red blood cells

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 2366 mg/kg/13W-C

TOXIC EFFECTS :: Endocrine - thyroid weight (goiter) Endocrine - other changes Nutritional and Gross Metabolic - weight loss or decreased weight gain

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 8652 mg/kg/2Y-C

TOXIC EFFECTS :: Tumorigenic - Carcinogenic by RTECS criteria Liver - tumors Endocrine - thyroid tumors

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 8550 mg/kg/76W-I

TOXIC EFFECTS :: Tumorigenic - equivocal tumorigenic agent by RTECS criteria Blood - leukemia Skin and Appendages - tumors

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 13 gm/kg/2Y-C

TOXIC EFFECTS :: Tumorigenic - Carcinogenic by RTECS criteria Sense Organs and Special Senses (Eye) - tumors Liver - tumors

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 7000 mg/kg/39W-I

TOXIC EFFECTS :: Tumorigenic - equivocal tumorigenic agent by RTECS criteria Lungs, Thorax, or Respiration - tumors Blood - leukemia

TYPE OF TEST :: TD - Toxic dose (other than lowest)

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 19 gm/kg/77W-I

TOXIC EFFECTS :: Tumorigenic - equivocal tumorigenic agent by RTECS criteria Kidney, Ureter, Bladder - Kidney tumors Blood - tumors

TYPE OF TEST :: TD - Toxic dose (other than lowest)

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 11 gm/kg/30W-I

TOXIC EFFECTS :: Tumorigenic - equivocal tumorigenic agent by RTECS criteria Lungs, Thorax, or Respiration - tumors Blood - leukemia

TYPE OF TEST :: TD - Toxic dose (other than lowest)

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 8652 mg/kg/2Y-C

TOXIC EFFECTS :: Tumorigenic - Carcinogenic by RTECS criteria Liver - tumors Endocrine - thyroid tumors

TYPE OF TEST :: TD - Toxic dose (other than lowest)

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 69216 mg/kg/2Y-C

TOXIC EFFECTS :: Tumorigenic - Carcinogenic by RTECS criteria Liver - tumors Endocrine - thyroid tumors

TYPE OF TEST :: TD - Toxic dose (other than lowest)

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 12978 mg/kg/2Y-C

TOXIC EFFECTS :: Tumorigenic - neoplastic by RTECS criteria Sense Organs and Special Senses (Eye) - tumors

TYPE OF TEST :: Specific locus test

TYPE OF TEST :: DNA damage

TYPE OF TEST :: Micronucleus test

MUTATION DATA

TYPE OF TEST :: Sister chromatid exchange

TEST SYSTEM :: Rodent - hamster Ovary

DOSE/DURATION :: 50 mg/L

REFERENCE :: SCIEAS Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- Volume(issue)/page/year: 236,933,1987 *** REVIEWS *** IARC Cancer Review:Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 29,203,1982 IARC Cancer Review:Human No Adequate Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 29,203,1982 IARC Cancer Review:Group 2B IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,56,1987 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-GERMANY;Carcinogen JAN 1993 OEL-RUSSIA:STEL 5 mg/m3 JAN 1993 OEL-SWITZERLAND;Carcinogen JAN 1993 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - T0239 No. of Facilities: 8 (estimated) No. of Industries: 1 No. of Occupations: 1 No. of Employees: 45 (estimated)

点击显示

4,4'-二氨基二苯醚(ODA)安全信息

[ 符号 ]:

GHS06, GHS08, GHS09

[ 信号词 ]:
Danger

[ 危害声明 ]:
H301 + H311 + H331-H317-H340-H350-H361-H410

[ 警示性声明 ]:
P201-P261-P273-P280-P301 + P310-P311

[ 个人防护装备 ]:
Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges

[ 危害码 (欧洲) ]:
T:Toxic

[ 风险声明 (欧洲) ]:
R45;R46;R62;R23/24/25;R51/53

[ 安全声明 (欧洲) ]:
S53-S45-S61-S36/37-S26-S20

[ 危险品运输编码 ]:
UN 3077 9/PG 3

[ WGK德国 ]:
3

[ RTECS号 ]:
BY7900000

[ 包装等级 ]:
III

[ 危险类别 ]:
6.1

[ 海关编码 ]:
29222900

4,4'-二氨基二苯醚(ODA)合成路线

详细合成路线

4,4'-二氨基二苯醚(ODA)上下游产品

4,4'-二氨基二苯醚(ODA)上游产品

4,4'-二氨基二苯醚(ODA)下游产品

4,4'-二氨基二苯醚(ODA)制备

(1)缩合反应将溶剂硝基苯515kg加入搅拌反应釜中，然后搅拌下将145kg硝基氯苯、123.5kg对硝基苯酚、95.7kg碳酸钠和6.18kg氯化钾依次加入搅拌反应釜中，搅拌下升温至210～215℃后，保持此温度下搅拌反应24h。缩合反应完成后，冷却，将缩合物抽至蒸馏装置，先进行真空蒸馏，当硝基苯蒸出350～400L时，改为水蒸气蒸馏，蒸至馏出液中无硝基苯时为止。剩余物经吸滤，滤液再用水洗涤至不带色，即制得4,4’-二硝基二苯醚。

(2)还原反应将丁醇918kg加入还原反应釜内，搅拌下加入10kg氯化铵，50kg铁屑，升温至95℃时加入4,4’-二硝基二苯醚25kg，搅拌反应0.5h。再加入第二批铁屑40kg，4,4’-二硝基二苯醚20kg，搅拌反应0.5h。然后加入第三批铁屑40kg，4,4’-二硝基二苯醚20kg，仍维持反应温度100℃，反应1.5h取样分析反应终点。反应结束后，加入亚硫酸氢钠12kg，搅拌溶解后，将反应物料趁热用管式吸滤器抽至结晶釜内冷却结晶约8h。然后经过过滤，滤液丁醇经蒸馏后循环使用，滤饼水洗至无丁醇为止，即得粗品4,4’-二氨基二苯醚。

(3)产品精制将340kg水、60kg30%的盐酸加入溶解槽，搅拌下加入粗品4,4’-二氨基二苯醚和1.5kg柠檬酸、1kg亚硫酸氢钠，加热升温至60℃，再加入活性炭9kg。继续升温至80℃，保持0.5h。冷却后过滤，将滤液加入中和槽，搅拌下加入亚硫酸氢钠0.5kg，再慢慢加入氨水，保持温度在30℃以下，中和至物料的pH值为8～9，则4,4’-二氨基二苯醚晶体从溶液中析出。经过滤，滤饼用水洗至中性及无氯离子存在，抽滤后进行真空干燥。

将干燥后的4,4’-二氨基二苯醚加入升华器中，抽真空至26.66Pa以下，加热升温至185～190℃，4,4’-二氨基二苯醚气化，进入结晶室，在结晶室内被冷却而结晶，结晶室温度控制在135～145℃。当结晶室温度显著下降时即升华结束，冷却升华器，使结晶室温度降至50℃时进行出料，即得成品。升华操作每批约需10h。

点击显示

4,4'-二氨基二苯醚(ODA)海关

[ 海关编码 ]: 2922299090

[ 中文概述 ]:
2922299090. 其他氨基(萘酚、酚)及醚、酯〔包括它们的盐, 但含有一种以上含氧基的除外〕. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:30.0%

[ 申报要素 ]: 品名, 成分含量, 用途, 乙醇胺及其盐应报明色度, 乙醇胺及其盐应报明包装

[ Summary ]:
2922299090. other amino-naphthols and other amino-phenols, other than those containing more than one kind of oxygen function, their ethers and esters; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

4,4'-二氨基二苯醚(ODA)文献

Spontaneous Generation of Chirality in Simple Diaryl Ethers.

Chirality 27 , 425-9, (2015)

We studied the spontaneous formation of chiral crystals of four diaryl ethers, 3-phenoxybenzaldehyde, 1; 1,3-dimethyl-2-phenoxybenzene, 2; di(4-aminophenyl) ether, 3; and di(p-tolyl) ether, 4. Compoun...

Development of QSAR models for predicting hepatocarcinogenic toxicity of chemicals.

Eur. J. Med. Chem. 44 , 3658-64, (2009)

A dataset comprising 55 chemicals with hepatocarcinogenic potency indices was collected from the Carcinogenic Potency Database with the aim of developing QSAR models enabling prediction of the above u...

Covalent molecular assembly of oligoimide ultrathin films in supercritical and liquid solvent media.

Langmuir 21(17) , 7812-22, (2005)

An ultrathin film of oligoimide has been fabricated on amine-modified substrates of silicon and quartz through alternate layer-by-layer (LBL) assembly of pyromellitic dianhydride (PMDA) and diaminodip...

更多文献

4,4'-二氨基二苯醚(ODA)

4,4'-二氨基二苯醚(ODA)用途

4,4'-二氨基二苯醚(ODA)名称

4,4'-二氨基二苯醚(ODA)物理化学性质

4,4'-二氨基二苯醚(ODA)MSDS

详细MSDS(安全技术说明书)

4,4'-二氨基二苯醚(ODA)毒性和生态

CHEMICAL IDENTIFICATION

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

MUTATION DATA

4,4'-二氨基二苯醚(ODA)安全信息

4,4'-二氨基二苯醚(ODA)合成路线

详细合成路线

4,4'-二氨基二苯醚(ODA)上下游产品

4,4'-二氨基二苯醚(ODA)上游产品

4,4'-二氨基二苯醚(ODA)下游产品

4,4'-二氨基二苯醚(ODA)制备

4,4'-二氨基二苯醚(ODA)海关

4,4'-二氨基二苯醚(ODA)文献

相关化工产品/化学物质：

推荐生产厂家/供应商：

相关化合物